AKT1 and neuroblastoma: We previously found that phosphorylated Akt correlates with poor patients' prognosis in NB [4], and the PI3K/Akt pathway has subsequently been linked to augmented cell survival [5] and increased resistance to chemotherapy in this tumor [6].